Combined Use of Etomidate and Propofol in Painless Gastroscopy.
- Conditions
- Safety of Gastroscopy
- Interventions
- Registration Number
- NCT01913054
- Lead Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Brief Summary
Gastroscopy, as a conventional examination for gastrointestinal tract disease, plays a very important role especially in early diagnosis and differential diagnosis of esophageal and gastric carcinoma. However, conventional gastroscopy is associated with several adverse effects (including throat discomfort, breath-holding, nausea, vomiting, laryngeal spasm and increased heart rate) due to which some patients are intolerant to this examination or even refuse the procedure due to fear of these effects. Recently, painless gastroscopy has been applied increasingly widely in outpatients to meet the increasing needs for comfortable medical care.
Painless gastroscopy is commonly performed under general anesthesia without establishing an artificial airway. This is associated with an even higher anesthetic risk than general anesthesia in the operating room due to more basic patient monitoring and life-supporting equipment, only one anesthetist to perform anesthesia, fatigue in anesthesia, the requirement for a high turnover rate, as well as limited understanding of a patient's condition. Therefore, the availability of sedatives and analgesics which can provide rapid onset, sufficient sedation and analgesia, a short recovery time and less adverse effects are the premise of performing painless gastroscopy. Currently, combined intravenous anesthesia with fentanyl and propofol, commonly used in the clinic, is still associated with a long duration of action, hypotension in some patients and prolonged recovery. Etomidate has been increasingly utilized for in-clinic diagnosis and treatment for procedures such as painless coloscopy and early induced abortion due to its rapid onset, rapid metabolism and minimal impact on the circulatory and respiratory systems. However, no study on combined intravenous anesthesia with fentanyl and etomidate for painless gastroscopy had previously been reported. The main purpose of this study is to explore the efficacy and safety of combined intravenous anesthesia with fentanyl and etomidate for painless gastroscopy compared with the combination of fentanyl and propofol in middle aged and elderly patients, and to provide reliable evidence for the implementation and promotion of comfortable medical care.
- Detailed Description
There are 6 centers for this trial: General Hospital of Chinese People's Liberation Army, Chaoyang Hospital Attached to the Capital Medical University, The Second Affiliated Hospital of Harbin Medical University, Renmin Hospital of Wuhan University Hubei General Hospital, The Affiliated Hospital of Xuzhou Medical College, Hospital of Chinese Air Force.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2450
- Preparing to take gastroscopy;
- Age:between 45 to 75 years old (middle-aged group: 45~59 years old; elderly group: 60~75 years old; the percentage of middle-aged group and elderly group are 60% and 40%, respectively);
- BMI: between 18 to 25 kg/m2;
- ASA classification: grade Ⅰ~Ⅱ.
- Blood pressure before operation: >180 mm Hg or <90 mm Hg;
- ECG before operation: <50 beats per min;
- HGB before operation: <90 g/L;
- Infected with respiratory inflammation and not cured within 2 weeks;
- Sever heart, brain, pulmonary, heptic, renal diseases or diabetes;
- History of difficult airway or abnormal recovery from anesthesia before or difficult airway is predicted to occur ;
- Obvious electrolyte disturbance such as hyperkalemia;
- Treated with immunosuppressants such as hormones for a long time or prior inhibition of the adrenal cortex;
- Allergic to emulsion or opioids;
- Concomitant other sedatives or analgesics (including injectable or oral administration of treatment related to Chinese Traditional Patent Medicines);
- Suspected abuse of narcotic analgesics or sedatives;
- Patients for whom it is difficult to cooperate or communicate because of abnormalities of neuromuscular system or mental disorder.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Fentanyl & Propofol Fentanyl Injection 0.02 ml/kg(1 μg/kg) fentanyl is diluted to 10 ml with normal saline and infused within 1 min, 4 min advance. 0.5 mg/kg(0.025 ml/kg) propofol is infused within 15 to 20 s. And then, depending on the randomized result, 0.5 mg/kg is given every time until the patient falls asleep. During the operation, 0.5 mg/kg is given when it is needed. Fentanyl & Propofol Propofol Injection 0.02 ml/kg(1 μg/kg) fentanyl is diluted to 10 ml with normal saline and infused within 1 min, 4 min advance. 0.5 mg/kg(0.025 ml/kg) propofol is infused within 15 to 20 s. And then, depending on the randomized result, 0.5 mg/kg is given every time until the patient falls asleep. During the operation, 0.5 mg/kg is given when it is needed. fentanyl, propofol & etomidate Etomidate Fat Emulsion Injection 0.02 ml/kg(1 μg/kg) fentanyl is diluted to 10 ml with normal saline and infused within 1 min, 4 min advance. 0.5 mg/kg(0.025 ml/kg) propofol is infused within 15 to 20 s. And then, depending on the randomized result, 0.5 mg/kg etomidate is given every time until the patient falls asleep. During the operation, 0.5 mg/kg etomidate is given when it is needed. fentanyl, propofol & etomidate Fentanyl Injection 0.02 ml/kg(1 μg/kg) fentanyl is diluted to 10 ml with normal saline and infused within 1 min, 4 min advance. 0.5 mg/kg(0.025 ml/kg) propofol is infused within 15 to 20 s. And then, depending on the randomized result, 0.5 mg/kg etomidate is given every time until the patient falls asleep. During the operation, 0.5 mg/kg etomidate is given when it is needed. fentanyl, propofol & etomidate Propofol Injection 0.02 ml/kg(1 μg/kg) fentanyl is diluted to 10 ml with normal saline and infused within 1 min, 4 min advance. 0.5 mg/kg(0.025 ml/kg) propofol is infused within 15 to 20 s. And then, depending on the randomized result, 0.5 mg/kg etomidate is given every time until the patient falls asleep. During the operation, 0.5 mg/kg etomidate is given when it is needed.
- Primary Outcome Measures
Name Time Method Blood pressure baseline to 10 min after the operation, an expected average of 20 minutes Changes of blood pressure in each group will be recorded.
- Secondary Outcome Measures
Name Time Method Heart rate baseline to the end of the operation, an expected average of 30 minutes Changes of heart rate in each group will be recorded.
Pulse Oxygen Saturation baseline to the end of the operation, an expected average of 10 minutes Changes of pulse oxygen saturation in each group will be recorded.
Respiratory rate baseline to the end of the operation, an expected average of 10 minutes Changes of respiratory rate in each group will be recorded
Trial Locations
- Locations (6)
The Affiliated Hospital of Xuzhou Medical College
🇨🇳Xuzhou, Jiangsu, China
General Hospital of Chinese Air Force
🇨🇳Peking, Beijing, China
Chaoyang Hospital Attached to the Capital Medical University
🇨🇳Peking, Beijing, China
General Hospital of Chinese People's Liberation Army
🇨🇳Peking, Beijing, China
Renmin Hospital of Wuhan University Hubei General Hospital
🇨🇳Wuhan, Hubei, China
The Second Affiliated Hospital of Harbin Medical University
🇨🇳Harbin, Heilongjiang, China